Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 48,251,727
- Share change
- +1,613,195
- Total reported value
- $1,682,950,642
- Put/Call ratio
- 26%
- Price per share
- $34.87
- Number of holders
- 127
- Value change
- +$59,932,851
- Number of buys
- 49
- Number of sells
- 62
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alphabet Inc. |
13F
|
Company |
3.8%
|
4,613,818
|
$126,695,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
4,038,728
|
$110,902,000 | — | 30 Jun 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.9%
|
3,498,260
|
$96,062,000 | — | 30 Jun 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.7%
|
3,335,247
|
$91,586,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
2.5%
|
3,091,165
|
$84,883,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
2.3%
|
2,797,822
|
$76,828,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,685,701
|
$73,749,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
2,466,442
|
$67,730,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
2,084,883
|
$57,251,000 | — | 30 Jun 2021 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
1.5%
|
1,842,077
|
$50,583,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
1.4%
|
1,663,568
|
$45,682,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.72%
|
876,038
|
$24,056,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
771,554
|
$21,186,000 | — | 30 Jun 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.62%
|
760,164
|
$20,874,000 | — | 30 Jun 2021 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.56%
|
687,540
|
$18,880,000 | — | 30 Jun 2021 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.55%
|
674,260
|
$18,515,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
668,181
|
$18,348,000 | — | 30 Jun 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.38%
|
463,398
|
$12,725,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.35%
|
425,074
|
$11,673,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
416,731
|
$11,444,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.31%
|
376,500
|
$10,339,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.29%
|
354,946
|
$9,746,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
344,559
|
$9,462,000 | — | 30 Jun 2021 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.25%
|
311,796
|
$8,562,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
298,410
|
$8,195,000 | — | 30 Jun 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.24%
|
297,088
|
$8,158,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
275,700
|
$7,571,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.22%
|
273,733
|
$7,517,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
269,458
|
$7,399,000 | — | 30 Jun 2021 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.22%
|
268,711
|
$7,379,000 | — | 30 Jun 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.2%
|
246,637
|
$6,773,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
232,138
|
$6,375,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
218,353
|
$5,997,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
203,411
|
$5,586,000 | — | 30 Jun 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.15%
|
189,454
|
$5,202,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
172,732
|
$4,743,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
163,269
|
$4,483,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
137,752
|
$3,783,000 | — | 30 Jun 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.1%
|
119,700
|
$3,287,000 | — | 30 Jun 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.09%
|
104,799
|
$2,878,000 | — | 30 Jun 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.09%
|
104,578
|
$2,872,000 | — | 30 Jun 2021 | |
| PARK CIRCLE Co |
13F
|
Company |
0.08%
|
100,000
|
$2,746,000 | — | 30 Jun 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.08%
|
93,506
|
$2,568,000 | — | 30 Jun 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.07%
|
86,438
|
$2,374,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
85,896
|
$2,359,000 | — | 30 Jun 2021 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.07%
|
85,225
|
$2,340,000 | — | 30 Jun 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.06%
|
75,290
|
$2,067,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.06%
|
75,000
|
$2,060,000 | — | 30 Jun 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.06%
|
75,000
|
$2,060,000 | — | 30 Jun 2021 | |
| Alpha Paradigm Partners, LLC |
13F
|
Company |
0.06%
|
71,951
|
$1,976,000 | — | 30 Jun 2021 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q3 2021
As of 30 Sep 2021,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,251,727 shares.
The largest 10 holders included
EcoR1 Capital, LLC, BlackRock Inc., Alphabet Inc., PFM Health Sciences, LP, BVF INC/IL, FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, BOXER CAPITAL, LLC, and Invus Financial Advisors, LLC.
This page lists
127
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
125
Q3 2021 holders
127
Holder diff
2
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.